Skip to main content

Pheochromocytoma Diagnosis News

Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas

MONDAY, April 29, 2024 – For patients with metastatic pheochromocytomas and paragangliomas (MPPGs), an antiangiogenic multi-tyrosine kinase inhibitor, cabozantinib, is promising, according to a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

clonidine